Breast Cancer Care (2012) Ductal carcinoma in situ (DCIS). [online, accessed 20 August 2015]

Breast Cancer Care (2013) Invasive ductal breast cancer. [online, accessed 20 August 2015]

Cancer Research UK (2014a) Breast cancer incidence statistics. [online, accessed 20 August 2015]

Cancer Research UK (2014b) Breast cancer mortality statistics. [online, accessed 20 August 2015]

Department of Health (2013) Payment by results 2013–14, payments by result (PbR) in the NHS. [online, accessed 04 August 2015]

Dogan BE, Le‑Petross C, Stafford JR et al. (2012) MRI-guided vacuum-assisted breast biopsy performed at 3 T with a 9-gauge needle: preliminary experience. American Journal of Roentgenology 199: W651–W3

Eby PR, Ochsner JE, DeMartini WB et al. (2009) Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge. American Journal of Roentgenology 192: 229–34

Eller AJ, Janka R, Lux M et al. (2014) Stereotactic vacuum-assisted breast biopsy (VABB) – A patients' survey. Anticancer Research 34: 3831–7

Hahn M, Kagan KO, Siegmann KC et al. (2010) Mammotome versus ATEC: a comparison of two breast vacuum biopsy techniques under sonographic guidance. Archives of Gynecology and Obstetrics 281: 287‑92

Health and Social Care Information Centre (2015) Hospital Episode Statistics, Admitted Patient Care, England - 2013–14: procedures and interventions. [online, accessed 4 August 2015]

Jemal A, Clegg LX, Ward E et al. (2004) Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 101: 3–27

Liberman L, Morris EA, Dershaw DD et al. (2003) Fast MRI-guided vacuum-assisted breast biopsy: initial experience. American Journal of Roentgenology 181: 1283–93

Order BM, Schaefer PJ, Peters G et al. (2013) Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome system 11G/8G vs. ATEC system 12G/9G. Acta Radiologica 54: 137–43

Public Health England (2010) Clinical guidelines for breast cancer screening assessment (Clinical Guideline No. 49). [online, accessed 23 October 2015]

Schaefer FK, Order BM, Eckmann‑Scholz C et al. (2012) Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome-system 11g/8g vs. ATEC-system 12g/9g. European Journal of Radiology 81: e739–45

Schrading S, Simon B, Braun M et al. (2010) MRI-guided breast biopsy: influence of choice of vacuum biopsy system on the mode of biopsy of MRI-only suspicious breast lesions. American Journal of Roentgenology 194: 1650–7